The Patient S Remedy

MADA labo · 2021 · $39.99 · Adventure · deal grade B

Measured on 2026-09-24 05:35 UTC, 12 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

Estimated net residual revenue: $384 to $575 per month
Opportunity: $623 per month at x1.30 dormancy
Estimated lifetime owners: 2.0k
98% positive across 52 reviews · 1.9 reviews/month

Why it's flagged

Developer active, last post 12 months ago
Studio active elsewhere (2 titles tracked), so this one may welcome a partner
Store page localized in only 2 language(s)

Analyst notes (AI-assisted)

Note written 2026-09-10; the live figures above take precedence over any numbers in it.

A 2021 BL visual novel centered on a patient-caregiver relationship, officially translated to English and built on a niche but underserved audience segment.

The Patient S Remedy occupies a quiet corner of Steam's visual novel catalog with genuinely strong community sentiment (98% positive) and steady micro-residuals, despite minimal marketing footprint and zero promotional activity in 12 months. The game's appeal to players seeking top-protagonist BL content appears durable if modest in scale. Revival opportunity exists primarily through community engagement and international localization expansion rather than major marketing spend; the title is better viewed as a catalog hold than a turnaround target, though a small publishing partner could sustain it with light care. Most realistic play: watch.

Risk: Extremely narrow audience (BL enthusiasts seeking specific protagonist archetype) constrains ceiling; mainstream appeal is not present.
Risk: Zero player base currently active and no discounting or promotion strategy in place suggests developer has moved focus elsewhere despite studio remaining operational.
Risk: No cloud save, achievements, or trading cards; minimal localization (91% English-language gap) may limit accessibility in growth markets.

This case as Markdown · Estimates carry ±30-50% error per title.